Florida healthcare giants Moffitt Cancer Center and Memorial Healthcare System have announced a new clinical partnership that seeks to broaden leukemia and lymphoma care, as well as establish a comprehensive Blood and Marrow Transplant Cellular Therapy Program for South Florida residents starting July 1.
"With both institutions recognized nationally and internationally as leaders in cancer care, this collaboration provides major benefits to patients seeking highly specialized cancer care close to home," the systems said in a statement.
The partnership enables Moffitt to provide blood and marrow transplant services, as well as malignant hematology, molecular diagnostics, personalized medicine and hematopathology. The physicians and other professionals staffing the new program at MHS will be employed by Moffitt.
"This is the first time Moffitt employed physicians will be practicing outside of the Tampa region and that helps us to further our legislative mandate to serve cancer patients across the state," said Louis B. Harrison, deputy physician-in-chief and chair of Moffitt's Department of Radiation Oncology. "It certainly helps patients even more when we can provide care close to home."
Memorial Healthcare System encompasses six hospitals, including a freestanding children's hospital, skilled nursing facility and home health agency. It is staffed by 2,200 physicians and roughly 13,000 employees.